Perception of patients with cancer towards support management services and use of complementary alternative medicine - a single institution hospital-based study in Saudi Arabia

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 6, 2014, Pages 2547-2554

  Sait, Khalid Hussain ^a   Anfinan, Nisrin Mohammad ^a   Eldeek, Basem ^a   Al Ahmadi, Jawher ^a   Al Attas, Maha ^a   Sait, Hesham Khalid ^a   Basalamah, Hussain Abdullah ^a   Al Ama, Nabeel ^a   El Sayed, Mohamed Eid ^a,b,c  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^b KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^c CAIRO UNIVERSITY   (Egypt)

Author keywords

Cancer; Complementary alternative medicine; Perception; Saudi Arabia; Services; Support

Indexed keywords

ADULT; AGED; ALTERNATIVE MEDICINE; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; DISEASE MANAGEMENT; FEMALE; FOLLOW UP; HEALTH CARE DELIVERY; HEALTH SERVICE; HUMAN; MALE; MIDDLE AGED; NEOPLASMS; ORGANIZATION AND MANAGEMENT; PATIENT SATISFACTION; PERCEPTION; PROGNOSIS; PSYCHOLOGY; QUESTIONNAIRE; SAUDI ARABIA; UTILIZATION;

ADULT; AGED; COMPLEMENTARY THERAPIES; CROSS-SECTIONAL STUDIES; DELIVERY OF HEALTH CARE; DISEASE MANAGEMENT; FEMALE; FOLLOW-UP STUDIES; HEALTH SERVICES; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PATIENT SATISFACTION; PERCEPTION; PROGNOSIS; QUESTIONNAIRES; SAUDI ARABIA;

EID: 84899825135     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.6.2547     Document Type: Article

References (59)

1. AARP, NCCAM (2007). Complementary and alternative medicine: what people 50 and older are using and discussing with their physicians. Washington, DC: AARP.
2. Aii FU, Wazaify M, Jabr M, Treish E (2010). The use of herbal preparations as complementary and alternative medicine (CAM) in a sample of patients with cancer in Jordan. Complement Ther Clin Pract, 16, 208-12.
3. Aggarwal BB, Kunnumakkara AB, Harikumar KB, et al (2008). Potential of spice-derived phytochemicals for cancer prevention. Planta Med, 74, 1560-9.
4. Alam AA (2006). Knowledge of breast cancer and its risk and protective factors among women in Riyadh. Ann Saudi Med, 26, 272-7.
5. Al-attas SA (2005). Knowledge, attitude and behavior about oral cancer, among a group of adult Jeddah population. Saudi Dental J, 17, 34-42.
6. Alferi SM, Antoni MH, Ironson G, Kilbourn KM, Carver CS (2001). Factors predicting the use of complementary therapies in a multi-ethnic sample of early-stage breast cancer patients. J Am Med Womens Assoc, 56, 120-3.
7. American Association of Retired Persons (2007). National Center for Complementary and Alternative Medicine. Complementary and Alternative Medicine: What People 50 and Older Are Using and Discussing With Their Physicians. Washington, DC: AARP.
8. Amin TT, Al Mulhim AR, Al Meqihwi A (2009). Breast cancer knowledge, risk factors and screening among adult Saudi women in a primary health care setting. Asian Pac J Cancer Prev, 10, 133-8.
9. Barnes PM, Powell-Griner E, McFann K, Nahin RL (2004). Complementary and alternative medicine use among adults: United States, 2002. Adv Data, 343, 1-19.
10. Bazerbashi S (2007). Cancer incidence for speciic site. National Saudi Cancer Registry. Riyadh (KSA): Ministry of Health.
11. Bernstein BJ, Grasso T (2001). Prevalence of complementary and alternative medicine use in cancer patients. Oncology, 15, 1267-72.
12. Berrigan D, Dodd K, Troiano RP, Krebs-Smith SM, Barbash RB (2003). Patterns of health behavior in US adults. Prev Med, 36, 615-23.
13. Bertakis KD, Azari R, Helms LJ, Callahan EJ, Robbins JA (2000). Gender differences in the utilization of health care services. J Fam Pract, 49, 147-52.
14. Bismark RS, Chen H, Dy GK, Gage-Bouchard EA, Mahoney MC (2014). Complementary and alternative medicine use among patients with thoracic malignancies: Support Care Cancer.
15. Boon H, Stewart S, Kennard M, et al (2000). Use of complimentary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions. J Clin Oncol, 18, 2515-21.
16. Boon HS, Olatunde F, Zick SM (2007). Trends in complementary/ alternative medicine use by breast cancer survivors: comparing survey data from 1998 and 2005. BMC Womens Health, 7, 4.
17. Boyle P, Levin B. World cancer report 2008. Lyon: International Agency for Research on Cancer; 2008.
18. Committee on the Use of Complementary and Alternative Medicine by the American Public IoM. Complementary and alternative medicine in the United States. Washington, DC: National Academies Press; 2005.
19. Edgar L, Remmer J, Rosberger Z, Fournier MA (2000). Resource use in women completing treatment for breast cancer. Psychooncology, 9, 428-38.
20. Ernstmann N, Neumann M, Ommen O, et al (2009). Determinants and implications of cancer patients' psychosocial needs. Support Care Cancer, 17, 1417-23.
21. Fox P Butler M, Coughlan B, Murray M, et al (2013). Using a mixed methods research design to investigate complementary alternative medicine (CAM) use among women with breast cancer in Ireland. Eur J Oncol Nurs, 17, 490-7.
22. Gansler T, Kaw C, Crammer C, Smith T (2008). A population- based study of prevalence of complementary methods use by cancer survivors: a report from the American Cancer Society's studies of cancer survivors. Cancer, 113, 1048-57.
23. Goldzweig G, Meirovitz A, Hubert A, et al (2010). Meeting expectations of patients with cancer: relationship between patient satisfaction, depression, and coping. J Clin Oncol, 28 1560-5.
24. Greenlee H, Kwan ML, Ergas IJ, et al (2009). Complementary and alternative therapy use before and after breast cancer diagnosis: the Pathways Study. Breast Cancer Res Treat, 117, 653-65.
25. Grzywacz JG, Suerken CK, Quandt SA, et al (2006). Older adults' use of complementary and alternative medicine for mental health: indings from the 2002 National Health Interview Survey. J Altern Complement Med, 12, 467-73.
26. Humpel N, Jones SC (2006). Gaining insight into the what, why and where of complementary and alternative medicine use by cancer patients and survivors. Eur J Cancer Care, 15, 362-8.
27. Matthews AK, Sellergren SA, Huo D, List M, Fleming G (2007). Complementary and alternative medicine use among breast cancer survivors. J Altern Complement Med, 13, 555-62
28. Mena M1, Wiafe-Addai B, Sauvaget C, et al (2014). Evaluation of the impact of a breast cancer awareness program in rural Ghana: a cross-sectional survey. Int J Cancer, 134, 913-24.
29. Meriam S, Merriam s ,Muhamad M (2013). Roles traditional healers play in cancer treatment in Malaysia: implications for health promotion and education. Asian Pac J Cancer Prev, 14, 3593-601.
30. Merckaert I, Libert Y, Messin S, et al (2010). Cancer patients' desire for psychological support: prevalence and implications for screening patients' psychological needs. Psychooncology, 19, 141-9.
31. Miller M, Boyer M, Butow P, Gattellari M, Dunn S, Childs A (1998). The use of unproven methods of treatment by cancer patients: frequency, expectations and cost. Supportive Care Cancer, 6, 337-47.
32. Muhamad M, Merriam S, Suhami N (2012). Why breast cancer patients seek traditional healers. Int J Breast Cancer, 2012, 689168.
33. Nagini S (2008). Cancer chemoprevention by garlic and its organosulfur compounds-panacea or promise. Anticancer Agents Med Chem, 8, 313-21.
34. Nazik E, Nazik H, Api M, Kale A, Aksu M (2012). Complementary and alternative medicine use by gynecologic oncology patients in Turkey. Asian Pac J Cancer Prev, 13, 21-5
35. NCCAM (National Center for Complementary and Alternative Medicine): http://nccam. nih.gov/health/whatiscam/ 2008.
36. Ni H, Simile C, Hardy AM (2002). Utilization of complementary and alternative medicine by United States adults: results from the 1999 national health interview survey. Med Care, 40, 353-8.
37. Opoku SY, Benwell M, Yarney J (2012). Knowledge, attitudes, beliefs, behavior and breast cancer screening practices in Ghana, West Africa. Pan Afr Med J, 11, 28.
38. Paltiel O, Avitzour M, Peretz T, et al (2001). Determinants of the use of complementary therapies by patients with cancer. J Clin Oncol, 19, 2439-48.
39. Pan SY, Gao SH, Zhou SF, et al (2012). New perspectives on complementary and alternative medicine: an overview and alternative therapy. Altern Ther Health Med, 18, 20-36.
40. Rabow MW, Dibble SL, Pantilat SZ, McPhee SJ (2004). The comprehensive care team: a controlled trial of outpatient palliative medicine consultation. Arch Intern Med, 164, 83-91.
41. Ravichandran K, Mohamed G, Al-Hamdan NA (2010). Public knowledge on cancer and its determinants among Saudis Khalid Hussain Sait et al in the Riyadh Region of Saudi Arabia. Asian Pac J Cancer Prev, 11, 1175-80.
42. Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE (2000). Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol, 18, 2505-14.
43. Ritvo P, Irvine J, Katz J, et al (1999). The patient's motivation in seeking complementary therapies. Patient Educ Couns, 38, 161-5.
44. Saghatchian M, Bihan C, Chenailler C, et al (2014). Exploring frontiers:Use of complementary and alternative medicine among patients with early-stage breast cancer. Breast. [Epub ahead of print]
45. Saibul N, Shariff ZM, Rahmat A, Sulaiman S, Yaw YH (2012). Use of complementary and alternative medicine among breast cancer survivors. Asian Pac J Cancer Prev, 13, 4081-6
46. Salmenpera L (2002). The use of complementary therapies among breast and prostate cancer patients in Finland. Eur J Cancer Care, 11, 44-50.
47. Saudi Cancer Registry (2010). Cancer incidence report, Saudi Arabia-2006. Kingdom of Saudi Arabia: Ministry of Health.
48. Shen J, Andersen R, Albert P, et al (2002). Use of complementary/ alternative therapies by women with advanced-stage breast cancer. BMC Complement Altern Med, 2, 1-7.
49. Shevchuk NA, Radoja S (2007). Possible stimulation of anti- tumor immunity using repeated cold stress: a hypothesis. Infect Agent Cancer, 2, 20-9.
50. Sparreboom A, Cox M, Acharya M, Figg W (2004). Herbal remedies in the United States: potential interactions with anticancer agents. J Clin Oncol, 22, 2489-503.
51. Suzuki N, N Takimoto Y, Suzuki R, et al (2013). Eficacy of oral administration of Lentinula eododes mycelia extract for breast cancer patients undergoing postoperative hormone therapy. Asian Pac J Cancer Prev, 14, 3469-72
52. Tarhan O, Alacacioglu A, Somali I, et al (2009). Complementary- alternative medicine among cancer patients in the western region of Turkey. J BUON, 14, 265-9
53. Truant TL, Porcino AJ, Ross BC, Wong ME, Hilario CT (2013). Complementary and alternative medicine (CAM) use in advanced cancer: a systematic review. J Support Oncol, 11, 105-13.
54. Ulger O, Yagli NV (2010). Effects of yoga on the quality of life in cancer patients. Complement Ther Clin Pract, 16, 60-3.
55. Wade C, Chao M, Kronenberg F, Cushman L, Kalmuss D (2008). Medical pluralism among American women: results of a national survey. J Womens Health (Larchmt), 17, 829-40.
56. Wanchai A, Armer JM, Stewart BR (2010). Complementary and alternative medicine use among women with breast cancer: a systematic review. Clin J Oncol Nurs, 14, 45-55
57. Wang HH1, Chung UL (2012). Use of complementary and alternative medicine among breast cancer survivors in Taiwan. Asian Pac J Cancer Prev, 13, 4789-92.
58. Wolsko PM, Eisenberg DM, Davis RB, Phillips RS (2004). Use of mind-body medical therapies. J Gen Intern Med, 19, 43-50.
59. Yildirim YK, Fadiloglu C, Uyar M (2006). Complementary therapies in palliative cancer care. Agri, 18, 26-32.